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Heteromeric KV7.1/KCNE1 channels conduct the cardiac
repolarizing current IKs that is crucial in the stress-mediated
adaptation of the myocyte action potential duration in a rate-
dependent way. Stress reactions via both β-adrenergic
stimulations1–3 and cortisol release along the hypothala-
mic–pituitary–adrenal axis4–6 are known to activate IKs
channels. IKs activation is important to increase repolariza-
tion forces at higher heart rates to counteract depolarizing
cardiac calcium currents.7 Impaired IKs function can result
from gene mutations, from pharmacological intervention,8
and/or from myocardial infections with Coxsackie virus B3,
as shown in a mouse model.9 Unbalanced ion ﬂuxes during
cardiac action potentials can thus lead to cardiac arrhythmias
and potentially cause sudden cardiac death.10–15
KV7.1 α-subunits alone form tetrameric KV channels
through an assembly domain in the intracellular C-terminus
of the channel protein.16,17 Furthermore, KV7.1 channels
coassemble with KCNE1 (minK) and the two engage in
dynamic interactions. The exact stoichiometry is under
intense debate and, so far, it is largely unknown whether
the KV7.1/KCNE1 stoichiometry is regionally variable in
different tissues or subregions of the heart.18
Mutations in the gene encoding either KV7.1 (KCNQ1) or
KCNE1 (KCNE1) have been associated with many inherited
forms of cardiac arrhythmia.19 In most of the cases, loss-of-KEYWORDS Long QT syndrome; Short QT syndrome; Channel; Structure;
Molecular (Heart Rhythm Case Reports 2016;2:521–529)
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).function mutations in KCNQ1 cause long QT syndrome
(LQTS) and associated ventricular arrhythmias termed
torsades de pointes.20 In contrast, gain-of-function mutations
in IKs channels are relatively rare and lead to the opposite
electrocardiogram (ECG) phenotype, short QT syndrome
(SQTS), and in some cases atrial ﬁbrillation.21–24
KCNE1 harbors one transmembrane segment, an extrac-
ellular N-terminus, and an intracellular C-terminus. Several
interaction points between KV7.1 and KCNE1 have been
identiﬁed on the extracellular side of the channel complex.25
Furthermore, a recent study of the positioning between the
KCNE1 extracellular domain structure26,27 and KV7.1
28
predicted several interaction sites.
In this study, we present a novel SQTS mutation, A287T,
and elucidate its pathophysiological mechanism to provide
novel insight into the α–β interaction.Methods
Clinical characterization
All probands who participated in the study gave written
informed consent in accordance with the last version of the
Declaration of Helsinki (World Medical Association and
R281) and with recommendations by the local ethics
committee.
We performed clinical and genetic investigations as
previously described.29 Brieﬂy, ECG analyses were per-
formed using conventional 12-lead ECG recordings and
standard lead positions (paper speed 50 mm/s), and heart
rate–corrected QT intervals (QTc) were calculated by
Bazett’s30 and by Fridericia’s formula.31 Genomic DNA
was isolated from blood lymphocytes by standard semi-
automatic procedures (QIAcube protocols; Qiagen, Venlo,pen access article under the CC BY-NC-ND license
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 Kv7.1 and KCNE1 form the cardiac IKs channel
complex. This channel current is a main component
of atrial and ventricular repolarization.
 The Kv7.1–KCNE1 structural interplay can be
altered by mutations in patients to result in
abnormal cardiac repolarization.
 Aberrant function of IKs can lead to long QT
syndrome (IKs loss of function) or, rarely, to short
QT syndrome (IKs gain of function).
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by investigating the major LQTS and SQTS genes, KCNQ1
(LQT1 or SQT2, GenBank Accession No. NM_000218.2;
LRG_287) and KCNH2 (LQT2 or SQT1, NM_000238.3;
LRG_288). Mutation nomenclature was done with the use of
the Alamut annotation software (Interactive Biosoftware,
Rouen, France) and annotation was in accordance with the
recommendations of the Human Genome Variation Society
(http://www.hgvs.org/mutnomen/). The control group con-
sisted of an in-house sample (n ¼ 380 healthy, unrelated
controls). Furthermore, variants were investigated for pres-
ence in the Exome Sequencing Project population of the
National Heart, Lung, and Blood Institute (http://evs.gs.
washington.edu/EVS/) and in ExAC (http://exac.broadinsti
tute.org/).In silico analysis and nucleotide variant
classiﬁcation
Potential pathogenic impact of missense variants was deter-
mined as described before.29 We used six different patho-
genicity prediction tools, namely KvSNP (http://www.
bioinformatics.leeds.ac.uk/KvDB/htdocs/php/KvSNP.php),
PolyPhen2 (http://genetics.bwh.harvard.edu/pph2/), SIFT
(http://sift.jcvi.org/), Mutation taster (http://www.muta
tiontaster.org/), MutPred (http://mutpred.mutdb.org/), and
SNPs&GO (http://snps-and-go.biocomp.unibo.it/snps-
and-go/). To determine the evolutionary protein conservation
of mutated residue sites, an orthologous alignment was
performed using ClustalW.Molecular biology
Oocyte expression plasmid constructs hKV7.1 (GenBank
Accession No. NM_000218) in pXOOM and hKCNE1
(NM_000219) in pSP64 have been previously described.25,32
Standard site-directed mutagenesis was performed to
generate the mutants A287T, A287C, A287D, A287E,
A287K, A287Q, A287S, T322A, and T322M. All constructs
were veriﬁed by DNA sequencing (Macrogen Inc, Seoul,
South Korea). The plasmids were linearized using NheI
for hKV7.1 and EcoRI for hKCNE1. In vitro synthesis of
cRNA was done using the T7 or SP6 mMessage mMachinekits (Ambion, Austin, TX) according to manufacturer’s
instructions.
Western blot
Oocytes were injected with 12 ng of KV7.1 wild-type
(KV7.1-WT) or mutant cRNA and 2.4 ng of KCNE1-WT
cRNA corresponding to a 6:1 molar ratio. For Western blot
analysis intact injected and uninjected/control oocytes (each
with 10 oocytes per preparation) were homogenized with a
P200 pipette in HbA buffer (in mM: 20 Tris-HCl, 5 MgCl2,
6H2O, 5 NaH2PO4, H2O, 1 EDTA, 80 sucrose, pH 7.4,
supplemented with protease inhibitor cOmplete, Roche
Lifescience, Mannheim, Germany). After centrifugation for
30 minutes at 16,000g, the supernatants were supplemented
with 4 μL sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis loading buffer (0.8 M β-mercaptoethanol,
6% SDS, 20% glycerol, 25 mM Tris-HCl, 0.1% bromphenol
blue, pH 6.8) per oocyte. Proteins from homogenized
oocytes were separated by SDS gel electrophoresis and
transferred to nitrocellulose membranes (Bio-Rad Laborato-
ries, München, Germany). Blots were blocked in phosphate-
buffered saline containing 1% Roti-Block (A151; Carl Roth,
Karlsruhe, Germany) for at least 1 hour at room temperature.
For the detection of KV7.1, membranes were incubated with
primary rabbit polyclonal anti–potassium channel KV7.1
antibody (1:100; AB5932; Merck Millipore, Darmstadt,
Germany), which detects a fragment of 70 kDa. As a
loading control, primary mouse monoclonal anti–beta 1
sodium potassium ATPase antibody (1:500; ab2873; Abcam,
Cambridge, UK) was used that recognizes a fragment of
35 kDa. Secondary antibodies were anti-rabbit IgG
(NA934) and anti-mouse IgG (NXA931), both in 1:10,000
dilution (GE Healthcare Life Science, Freiburg, Germany).
For veriﬁcation of protein levels, Ponceau Red staining was
performed. Labeled proteins were detected by an enhanced
chemiluminescence reaction (Immuno Cruz, A1713; Santa
Cruz Biotechnology, Dallas, TX).
Electrophysiology
Xenopus laevis oocytes were obtained from EcoCyte Bio-
science (Castrop-Rauxel, Germany). Oocytes were injected
with 12 ng of KV7.1-WT or mutant cRNA and 2.4 ng of
KCNE1-WT cRNA. In the case of variable stoichiometry the
amounts of cRNA were 12 ng of KV7.1 plus 12 ng of
KCNE1 (molar ratio of 1.3:1), plus 2.4 ng of KCNE1 (6:1),
plus 1.2 ng of KCNE1 (13:1) or plus 0.12 ng of KCNE1
(130:1). The oocytes were incubated for 3–4 days at 181C
in Barth’s solution containing (in mM): 88 NaCl, 1.0 KCl,
2.4 NaHCO3, 0.33 Ca(NO3)2, 0.4 CaCl2, 0.8 MgSO4, 5 Tris-
HCl, pH 7.6, supplemented with penicillin-G (63 mg/L),
gentamicin (100 mg/L), streptomycin sulfate (40 mg/L), and
theophylline (80 mg/L). Standard 2-electrode voltage-clamp
(TEVC) recordings were conducted at 221C using a Turbo
Tec-10CD ampliﬁer (NPI Electronics, Tamm, Germany),
Digidata 1322A AD/DA-interface, and pCLAMP 9.0 soft-
ware (Axon Instruments Inc/Molecular Devices, Sunnyvale,
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(Molecular Devices), Prism6 (GraphPad Software, La Jolla,
CA), and OriginPro 9.0 (Additive, Friedrichsdorf, Ger-
many). Recording pipettes were ﬁlled with 3 M KCl and
had resistances of 0.5–1.0 MΩ. Recording solution ND96 (in
mM: 96 NaCl, 4 KCl, 1.8 MgCl2, 1.0 CaCl2, 5 HEPES) was
used to record standard currents. In the case of high Kþ or
high Rbþ solutions, 100 mM KCl or 100 mM RbCl were
added to ND96 solution. The pH was equilibrated to 7.6 in
all recording solutions.
Molecular dynamics simulations
We used the KV7.1/KCNE1 structural model from Xu et al
28
and introduced the mutation A287T in all 4 KV7.1 subunits
to obtain the mutant channel. Energy minimizations were
performed on the WT KV7.1/KCNE1 model and the new
KV7.1-A287T/KCNE1 model in parallel using the
AMBER03 force ﬁeld with the identical setting. The models
were incorporated into membranes and 0.9 % NaCl and
before all-atoms-mobile simulations were performed for
10ns to reach stable conformations using YASARA Struc-
ture version 10.1 (YASARA Biosciences GmbH, Vienna,
Austria), as previously described.33 Structural analyses
were performed using customized scripts based on
YASARA scripts md-analyze, md-analyzeres, md-ana-
lyzestr, md-analyzemul, and Discovery Studio 4.0 (Accelrys,
San Diego, CA). Mathematical and graphical analysis were
performed using OriginPro 9.0 (Additive, Friedrichsdorf,
Germany).
Results
Clinical and genetic characterization
We followed up on a 16-year-old female patient (family
10919-1) who survived cardiac arrest after ventricular
ﬁbrillation. Cardiopulmonary resuscitation after this ﬁrst
cardiovascular symptom was successful and she reco-
vered without a neurologic deﬁcit. There was no evi-
dence for any medications, electrolyte imbalances, or other
abnormalities.
Electrocardiographic ﬁndings were shortened QTc
(333 ns) intervals. The PQ value was 116 ms and the P-wave
and T-wave morphology was normal (ECG, Figure 1A).
According to current criteria,34 an SQTS (owing to a QTc
o360 ms and cardiac symptoms) was diagnosed. An invasive
electrophysiological study failed to induce ventricular tachyar-
rhythmia. Finally, an implantable cardioverter-deﬁbrillator was
implanted for secondary prophylaxis. During a follow-up of two
years, one episode of a supraventricular tachycardia (143 beats
per minute) was noticed despite long-term treatment with β-
receptor blockers. However, after three years another episode of
ventricular ﬁbrillation occurred which was adequately termi-
nated by implantable cardioverter-deﬁbrillator shock. Two other
female mutation carriers (mother, aunt) had a normal QT
interval and did not show any clinical symptoms.
Genetic testing in major SQTS genes (KCNQ1, KCNH2,
KCNJ2) identiﬁed a novel heterozygous nucleotide exchangec.859 G4A in exon 7 of the KCNQ1 gene. This mutation
predicted an amino acid substitution, p.Ala287Thr (Figure 1B
and C). This nonsynonymous variation was absent in controls
as well as in the mutation repository underlying the National
Heart, Lung, and Blood Institute GO Exome Sequencing
Project. Alanine at amino acid position 287 revealed a high
degree of orthologous conservation (Figure 1D). Several
pathogenicity prediction programs (KVSNP, SNPs&GO,
Mutation taster SIFT, and PolyPhen2) judged this variation
uniformly as being deleterious/pathogenic, while MutPred
evaluated a lower probability for a deleterious mutation
(0.381).
KV7.1-A287T shows a gain-of-function phenotype
and affects KV7.1 ion conduction
To elucidate the underlying molecular mechanism, we
performed TEVC experiments comparing WT and mutant
channels (brieﬂy: KV7.1-A287T) in Xenopus laevis oocytes.
As illustrated in Figure 2A and B, KV7.1-A287T exhibited
signiﬁcantly increased peak current amplitudes compared
with KV7.1-WT channels. This gain-of-function phenotype
was even more pronounced when the channel was coex-
pressed with its β-subunit KCNE1.
Next, we addressed whether the gain-of-function pheno-
type may be a result of altered conductance through the
selectivity ﬁlter (Figure 2C–E). The selectivity ﬁlter of
KV7.1 allows for increased Rb
þ conductance rates compa-
rable to Kþ conductance rates, an effect strictly correlating
with a fast ﬂicker block event in the channel.35 This effect is
reduced when KV7.1 is coexpressed with KCNE1, and the
fast ﬂicker block is a major determinant of maximal
conduction through the channel complex.35 We utilized the
Rbþ/Kþ effects to assess whether the mutation A287T may
affect the fast ﬂicker block and its modulation by KCNE1.
When exchanging extracellular Kþ by Rbþ, the inward
currents through the KV7.1 pore were increased by a factor of
about 2 in WT but only by approximately 1.5 in KV7.1-
A287T. On the contrary, Rbþ inward currents compared
with Kþ inward currents were slightly reduced in KV7.1-
WT/KCNE1 and remained unaffected in KV7.1-A287T/
KCNE1. Therefore, both A287T mutations of homomeric
KV7.1 and heteromeric KV7.1/KCNE1 channels results in
reduced Rbþ vs Kþ selectivity. However, the degree of
KCNE1 modulation in A287T is reduced.
The amino acid position A287 is a structurally
relevant key amino acid
To better understand these ﬁndings, we generated an in silico
homology model of the KV7.1 transmembrane domain
(Figure 3). The residue A287 was localized at a position
that allowed the formation of a hydrogen bond between the
hydroxyl group of T322 and the backbone of A287. This
hydrogen bond potentially stabilizes the outer pore domain
within one KV7.1 subunit (Figure 3A). To analyze this
possible interaction, we replaced the alanine at position 287
with threonine, cysteine, asparagine, lysine, glutamine, or
Figure 1 Clinical characterization. A: Twelve-lead electrocardiogram (ECG) at 50 mm/s of index patient with SQT: Heart rate of 46/min, normal P-wave
duration (82 ms) and QRS duration (96 ms), but PQ interval at the lower limit (116 ms, no pre-excitation) and QT interval of 380 ms, corresponding to a short
QTc interval (Bazett’s correction: 333 ms; Fridericia’s correction: 348 ms). No isoelectric ST segment or early repolarization was observed. B: Membrane
topology of the predicted KV7.1 protein structure and localization of the two identiﬁed mutations.C: Representative electropherogram of index patient with SQT
bearing the mutation c.859G4A (p.Ala287Thr) in KCNQ1. D:Multiple-sequence alignment of human Kv7.1 protein (aa 281–293) with corresponding regions
of orthologous protein sequences. Identical amino acids are indicated by an asterisk, highly conserved amino acids are indicated by a colon, and semiconserved
amino acids are indicated by a dot in the lower lane. The mutated amino acid residue 287 is highlighted in bold. E: Baseline and exercise ECG of index patient
with a heterozygous LQT1 mutation (Thr322Met), showing a borderline QT interval at rest (440–450 ms) and paradoxical prolongation at higher heart rates (up
to 480 ms).
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Figure 2 Heterologous expression of KV7.1-WT and KV7.1-A287T channels in absence and presence of KCNE1 in Xenopus laevis oocytes suggests a gain-
of-function of mutant channels associated with altered Kþ vs Rbþ sensitivity.A: Representative current traces of KV7.1-WT and mutant KV7.1-A287T (A287T)
in absence or presence of KCNE1. Oocytes were injected with 12 ng KV7.1-WT or mutant cRNA and 2.4 ng KCNE1-WT cRNA (molar ratio of 6:1). Currents
were elicited with 7-second pulses to potentials of -100 toþ60 mV in 10-mV increments from a holding potential of -80 mV. B: Current–voltage relationship of
KV7.1 and mutant KV7.1-A287T in absence or presence of KCNE1 (n ¼ 14–33, standard error of the mean). C: Representative current traces for KV7.1-WT
and the mutant A287T channel elicited by a 7-second pulse to þ40 mV pulse and a return to -120 mV. Currents were recorded in high Kþ (black trace) and in
high Rbþ solution (red trace). D: Tail current amplitudes at -120 mV after a þ40 mV activating pulse in high extracellular concentrations of Kþ and Rbþ were
assessed for homomeric/heteromeric wild-type and mutant channels. GRbþ/GKþ are shown (n ¼ 10–14). E: Relations of GRbþKv7.1/GKþKv7.1/KCNE1 and
GRbþA287T/GKþA287T/KCNE1 (simpliﬁed named here as “rel. GRbþ/GKþ by KCNE1”; mean data from B were used).
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TEVC experiments. Furthermore, we exchanged threonine
322 with alanine and methionine. Several mutant channels at
residue 287 (A287T/C/E/K/Q/S) exhibited typical gain-of-
function effects as compared with WT channels (Figure 3B).
In contrast, mutants T322A, T322M, and also A287D
expressed in oocytes exhibited largely reduced ion currents
(Figure 3B) and thus were consistent with a reduced
repolarization force. Of note, T322M has been linked to
LQT136 and we had also identiﬁed this mutation in a small
family with typical LQTS (4.1E). To address whether these
differences were due to altered protein expression, we
performed Western blot experiments using oocytes express-
ing the different mutant channels. We observed similar
expression levels of the mutated KV7.1 proteins as compared
with KV7.1-WT, which rules out that the impaired proteinfunction is due to reduced expression levels (Figure 3C
and D).
Next, we sought to identify molecular properties of
residue 287 by analyzing the effects of charge, volume,
and hydrophobicity at this position on channel function.
However, we did not observe a correlation of current
amplitudes with any of these features (Supplementary
Figure S1, available online). The voltage dependence of
activation V1/2 was shifted to depolarized potentials by all
mutants except A287T, whereas slope (k) was altered by all
mutations (Supplementary Figure S2, available online).
When coexpressed with KCNE1, only mutant KV7.1-A287T
showed a clear shift of the voltage dependence of channel
activation toward more hyperpolarized potentials. However,
owing to the nonsaturating character of KV7.1/KCNE1 chan-
nel currents no clean Boltzmann ﬁt was possible.
Figure 3 Analysis of homomeric and heteromeric KV7.1-WT and mutant channels (molar ratio 6:1) do not exert a clear correlation of functional effects with
simple chemical side chain features. A: Three-dimensional model of segment S5 and S6 of KV7.1 channel suggesting an interaction of KV7.1-A287 with KV7.1-
T322. B: Normalized current amplitudes of KV7.1-A287 and KV7.1-T322 compared with KV7.1-WT in absence or presence of KCNE1. Change in current
measured at the end of a 7-second pulse toþ40 mV (n¼ 10–34, standard error of the mean, unpaired t test, ****Po .0001). C: Representative Western blot
depicting KV7.1 surface membrane expression in Xenopus laevis oocytes in absence (-) and presence (þ) of KCNE1.D: Representative current trace ofþ40 mV
pulse in absence or presence of KCNE1. Currents were elicited with 7-second pulses to potentials of -100 to þ60 mV in 10-mV increments from a holding
potential of -80 mV. E, F: Activation curves of KV7.1-WT and mutant KV7.1 (A287T) in absence or presence of KCNE1. Curves were obtained by
normalization of initial tail currents to the respective value at þ60 mV.
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position 287 is a key residue for KV7.1–KCNE1
interaction
Lastly, we performed molecular dynamics simulations
(Supplementary Figure S3, available online) using a recently
published model of the KV7.1/KCNE1 complex.
28 A287T
was inserted into the model and energy minimization was
performed on both mutant and WT models. Molecular
modeling simulations were then carried out on both models
in parallel. The channels were incorporated into membranes
and simulated in 0.9% NaCl for 10 nanoseconds, with all
atoms being mobile. Both models reached stable conforma-
tions within this time frame, as indicated by an acquired
steady state (root mean square deviation value approaching
plateau, Supplementary Figure S3D). In average structures
overlaid in Supplementary Figure S3A, we observed that the
selectivity ﬁlter was slightly rearranged in the KV7.1-A287T
model. Furthermore, the outer domain of both KCNE1
subunits (colored in red) was largely repositioned, whereasthose of WT-channel complexes stayed in position (yellow).
Magniﬁcation of the area of interest (Supplementary Figure
S3B) shows a stable interaction between A287 and T322 of
the same KV7.1 subunit and with Q23 of the adjacent
KCNE1 β-subunit. On the contrary, KV7.1-A287T causes
some local rearrangements that affect the outer KCNE1
structure (Supplementary Figure S3 and Supplementary
Table S1, available online). Although KV7.1-A287 still
interacts with KV7.1-T322 and KCNE1-Q23, additional
stable interactions with KV7.1-Q323 and KCNE1-G40 could
be observed in silico (Supplementary Figure S3C). The
rearrangement of the outer KCNE1 induced changes in the
dynamics of the channel complex. In KCNE1 we detected
changes in a measure of conformational freedom of a residue
(root mean square ﬂuctuations, RMSF) in the outer domain
but not in the transmembrane segment (Supplementary
Figure S3E). Furthermore, differences in RMSF of residues
in the S3–S4 linker, the outer S5–pore helix linker, and the
outer vestibule close to the selectivity ﬁlter could be
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domain structure in the region of residues 23–40 was
markedly changed in both KCNE1 subunits of the KV7.1-
A287T/KCNE1 channel complex (Supplementary Figure
S3E). The RMSF of KV7.1-A287T itself was reduced within
both KV7.1-KCNE1 interaction regions compared with the
simulation in the same subunit. This reduction may result
from strengthened backbone interactions with KV7.1-T322
(by the proposed H-bond), as indicated by the reduced
RMSD in the backbones (Supplementary Table S2, available
online). In sum, these simulations show that (1) residue
KV7.1-A287 is forming a stable H-bond to allow for a correct
selectivity ﬁlter structure and that (2) interaction with
KCNE1-Q23 allows for correct KCNE1-KV7.1 interaction
in silico. Thus, KV7.1-A287 is a key residue both for normal
KV7.1 selectivity structure and normal KCNE1 interaction.
This is impaired in disease-associated KV7.1-A287T/
KCNE1 channels based on in silico simulations.Discussion
Our clinical investigation indicates that the patient carrying
KV7.1-A287T is presented with a prominent SQT2, imply-
ing an accelerated ventricular repolarization. This is consis-
tent with other SQT2 mutations, which all cause a gain-of-
function phenotype in heterologous expression systems.37
We thoroughly characterize KV7.1-A287, which associates
in the short repolarization disorder (SQT2). Our data indicate
a shift of the voltage-dependent activation of IKS channels
toward hyperpolarization, meaning that more channels
activate faster and generate a higher macroscopic current
amplitude (Figure 2A and B). Thus, the characterized
mutation A287T elicited a classic gain of function involving
increased voltage dependence.
We show that the alanine residue at position 287 in
KCNQ1 is crucial for normal channel function. Possibly, the
gain-of-function phenotype could be a result of altered
conductance through the selectivity ﬁlter substantiated by
localization of A287 in the S5 segment of KV7.1 near the
pore. Our results show that the conductance ratio of Rbþ/Kþ
is smaller in KV7.1-A287T compared with WT channels and
KV7.1 conducts Rb
þ much better than Kþ, an effect that is
inversed upon KCNE1 coassembly.35,38,39 The clear inver-
sion by coexpression with KCNE1 is much milder in the
mutant channel complex. This shows that the KCNE1 effects
on fast ﬂicker block, a well-known KCNE1 effect on the
selectivity ﬁlter, are reduced in KV7.1-A287T mutant
channels (Figure 2C–E). Thus, the inﬂuence of rate-
limiting fast ﬂicker block in Kv7.1/KCNE1 channels may
be reduced in A287T channels, additionally contributing to
the gain-of-function phenotype beside increased channel
availability owing to increased voltage dependence.
Our data substantiate the crucial role of alanine at position
287 for physiological channel function. We performed a
wide-range amino acid substitution at position A287 and
T322 inKCNQ1. Substitutions of amino acids at this location
caused gain-of-function or loss-of-function phenotypes(Figure 3). Our systematic mutational analysis indicates
that alanine, with its short neutral side chain, is key for
channel function in that amino acid substitutions in this
position are not well tolerated. This ﬁnding is in agreement
with the 3-dimensional model, in which the methyl
group interacts with KCNE1 to allow for precise
KV7.1/KCNE1 arrangement. Interestingly, there is no clear
correlation between gain/loss of function and biochemical
features due to amino acid exchange at KV7.1-287
(charge, volume, or hydrophobicity; Supplementary
Figure 2A–F).
Based on homology modeling, KV7.1-A287 (backbone)
is predicted to form an H-bond with T322 (Figure 3A).
Mutations KV7.1-T322A and KV7.1-T322M cause a severe
loss of function, as shown here (Figure 3), and were reported
to be associated with LQT1.36,40,41 Both mutations can be
expected to disrupt the H-bond because the H-donor in the
threonine side chain is eliminated by the mutation. Interest-
ingly, both KV7.1-T322M and KV7.1-T322A do reach the
plasma membrane and thus, the H-bond may rather be
important for intrinsic protein function (Figure 3C). This
interaction may be important to stabilizing the arrangement
of S5, S6, and the central pore domain/selectivity ﬁlter.
Indeed, this arrangement was reported to affect the selectiv-
ity ﬁlter, conductance, and ion selectivity.42 Elimination of
the proposed H-bond between KV7.1-A287 with KV7.1-
T322 by LQT1 mutations KV7.1-T322A or KV7.1-T322M
gives rise to nonfunctional channels that are plasma mem-
brane associated. The lack of function of these channels must
therefore result from mutational effects that are intrinsic to
the channel protein structure rather than from trafﬁcking
defects (Figure 3B–D). The simple distance analysis sug-
gests that the KV7.1-A287 residue interacts with the
KCNE1-Q23 residue in silico as well (Supplementary
Figure S3). Van der Waals interaction may stabilize the
KV7.1-KCNE1 subunit arrangement at this site in the outer
region. Mutant KV7.1 subunits (A287T) would change these
local interactions, thereby structurally increasing rigidity at
KV7.1-A287T (Supplementary Table 2). Further, structural
motifs in the outer KCNE1 domain (Supplementary Figure
S3) are impaired, as suggested by our molecular dynamics
simulations. The simulations were performed using a 3-
dimensional model28 that is based on modeling and cys-
crosslinking experiments in the region under investigation in
this present study. Thus, according to our in silico predic-
tions, the triad of KV7.1-T322, KV7.1-A287, and KCNE1-
Q23 is expected to be crucially important for KV7.1/KCNE1
channel complex function.
This predicted functional triad is compromised by muta-
tion KV7.1-A287 to cause:– Extensive functional effects depending on the speciﬁc
amino acid present at position 287;– Atypical inﬂuences of KCNE1 on ion channel
conductance;– Modiﬁed KV7.1 ion selectivity. A287 mutations inﬂuence
the structural arrangement of S5, S6, and the central pore
Heart Rhythm Case Reports, Vol 2, No 6, November 2016528domain/selectivity ﬁlter, which is of high relevance to ion
selectivity and conductance.42
Conclusion
We have identiﬁed a structural triad formed by two distinct
residues in KV7.1 (T322 and A287, respectively) and one
residue in KCNE1 (Q23) that is essential for regular KV7.1-
KCNE1 subunit interaction. Structural disturbances at these
residues, for example by human LQT gene mutations,
exhibit opposite effects of IKs channel function and may
result in either a gain-of-function or a loss-of-function
phenotype with clinically shortened (SQT) or prolonged
(LQT) repolarization. These patients may suffer not only
from fatal ventricular arrhythmias, but also at times from
atrial arrhythmias.
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